Abstract
Immunofluorescence and immunogold labelling were used to localise the 43-kDa dystrophinassociated glycoprotein (43DAG) of the dystrophin-glycoprotein complex in control and Duchenne muscular dystrophy (DMD) biopsies. In control muscle 43DAG was localised by immunofluorescence to the periphery of the fibre and, by immunogold, was further delimited to the plasma membrane. The labelling was indistinguishable from that previously reported for the dystrophin C terminus [5]. Moreover, the distance separating adjacent 43DAG labelling sites (120 nm mode) closely matched that separating dystrophin C-terminal sites. This is strong evidence supporting Ervasti & Campbell's model in which the DAG complex is bound close to the C terminus of dystrophin and in which the DAG complexes are separated by approximately the length of the dystrophin rod [7, 12]. In DMD, where there is a 80–90% reduction in the glycoprotein complex [16], a faint or locally patchy distribution of 43DAG was seen by immunofluorescence. Measurement of nearest-neighbour distances after immunogold labelling showed that in DMD the 43DAG was more dispersed, which is further evidence that dystrophin is normally involved in anchoring the DAGs in the plasma membrane. This is significant because the potential success of dystrophin gene therapy could depend not only on restoring dystrophin but also on restoring the lost DAGs.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ahn AH, Kunkel LM (1993) The structural and functional diversity of dystrophin. Nature Genet 3: 283–291
Bowman W (1840) On the minute structure and movements of voluntary muscle. Phil Trans R Soc Lond [B] 130: 457–501
Campbell KP, Kahl SD (1989) Association of dystrophin and an integral membrane glycoprotein. Nature 338: 259–262
Cullen MJ, Walsh J, Nicholson LVB, Harris JB (1990) Ultrastructural localization of dystrophin in human muscle using gold immunolabelling. Proc R Soc Lond [B] 240: 197–210
Cullen MJ, Walsh J, Nicholson LVB, Harris JB, Zubrzycka-Gaarn EE, Ray PN, Worton RG (1991) Immunogold labelling of dystrophin in human muscle, using an antibody to the last 17 amino acids of the C terminus. Neuromusc Disord 1: 113–119
Ervasti JM, Campbell KP (1991) Membrane organization of the dystrophin-glycoprotein complex. Cell 66: 1121–1131
Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345: 315–319
Gorospe JRM, Hoffman EP (1992) Duchenne muscular dystrophy. Curr Opin Rheumatol 4: 794–800
Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355: 696–702
Levine BA, Moir AJG, Patchell VB, Perry SV (1990) The interaction of actin with dystrophin. FEBS Lett 263: 159–162
Matsumura K, Tomé FMS, Collin H, Azibi K, Chaouch M, Kaplan J-C, Fardeau M, Campbell KP (1992) Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy. Nature 359: 320–322
Matsumura K, Campbell KP (1993) Deficiency of dystrophin-associated proteins: a common mechanism leading to muscle cell necrosis in severe childhood muscular dystrophies. Neuromusc Disord 3: 109–118
Minetti C, Beltrame F, Marcenaro G, Bonilla E (1992) Dystrophin at the plasma membrane of human muscle fibers shows a costameric localization. Neuromusc Disord 2: 99–109
Nicholson LVB, Davison K, Johnson MA, Slater CR, Young C, Bhattacharya S, Gardner-Medwin D, Harris JB (1989) Dystrophin in skeletal muscle. II Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci 94: 137–146
Ohlendieck K, Ervasti JM, Matsumura K, Kahl SD, Leveille CJ, Campbell KP (1991) Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron 7: 499–508
Ohlendieck K, Matsumura K, Ionasescu VV, Towbin JA, Bosch EP, Weinstein SL, Sernett SW, Campbell KP (1993) Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology 43: 795–800
Pardo JV, Siliciano JD, Craig SW (1983) A vinculin-containing cortical lattice in skeletal muscle: transverse lattice elements (‘costamers’) mark sites of attachment between myofibrils and sarcolemma. Proc Natl Acad Sci USA 80: 1081–1088
Porter GA, Dymtrenko GM, Winkelmann JC, Bloch RJ (1992) Dystrophin colocalizes with β-spectrin in distinct subsarcolemmal domains in mammalian skeletal muscle. J Cell Biol 177: 997–1005
Straub V, Bittner RE, Leger JJ, Voit T (1992) Direct visualization of the dystrophin network on skeletal muscle fiber membrane. J Cell Biol 119: 1183–1191
Suzuki A, Yoshida M, Yamamoto H, Ozawa E (1992) Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain. FEBS Lett 308: 154–160
Vater R, Cullen MJ, Nicholson LVB, Harris JB (1992) The fate of dystrophin during the degeneration and regeneration of the soleus muscle of the rat. Acta Neuropathol 83: 140–148
Way M, Pope B, Cross RA, Kendrick-Jones J, Weeds AG (1992) Expression of the N-terminal domain of dystrophin in E. coli and demonstration of binding to F-actin. FEBS Lett 301: 243–245
Yoshida M, Ozawa E (1990) Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem 108: 748–752
Author information
Authors and Affiliations
Additional information
Supported by the Muscular Dystrophy Group of Great Britain (Grant No. PG4/3)
Rights and permissions
About this article
Cite this article
Cullen, M.J., Walsh, J. & Nicholson, L.V.B. Immunogold localization of the 43-kDa dystroglycan at the plasma membrane in control and dystrophic human muscle. Acta Neuropathol 87, 349–354 (1994). https://doi.org/10.1007/BF00313603
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00313603